[Pathophysiology of and therapy for primary myelofibrosis].
D000818:Animals; D016207:Cytokines; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D009154:Mutation; D055728:Primary Myelofibrosis / Q000209:etiology* / Q000628:therapy*; D015398:Signal Transduction; D013792:Thalidomide / Q000627:therapeutic use; D016212:Transforming Growth Factor beta; D014184:Transplantation, Homologous